Location History:
- Tokyo, JP (2013 - 2015)
- Nishitokyo, JP (2019 - 2021)
Company Filing History:
4 out of 4,240 
2 out of 389 
Years Active: 2013-2021
Title: Takuji Aimiya: Innovator in Nanoparticle Technology
Introduction
Takuji Aimiya is an esteemed inventor based in Nishitokyo, Japan, known for his significant contributions to the field of nanoparticle technology. With four patents to his name, Aimiya has made strides in developing innovative solutions that enhance the diagnostic capabilities of medical imaging and tissue staining.
Latest Patents
Aimiya's latest patents reflect his commitment to advancing cancer diagnostics and biological research. One of his key inventions is the "Phosphor integrated dots nanoparticles and labeling agent using same." This innovative nanoparticle incorporates a hydrophobic fluorescent substance within a thermosetting resin matrix. When utilized for labeling biological substances such as proteins or nucleic acids, it provides sufficient brightness for effective pathological diagnosis through fluorescence imaging.
His other recent patent involves a revolutionary "Tissue staining method with staining agent containing particle holding plural phosphors." This method allows for precise evaluation of biosubstance expression levels in tissues by staining them with a reagent that bonds to particles carrying multiple fluorescent substances. The measurement of fluorescent brightness or counting fluorescent points aids in determining the presence of specific biosubstances, enhancing the accuracy of tissue analysis.
Career Highlights
Aimiya is affiliated with Konica Minolta, Inc., where he leverages his expertise to further develop innovative technologies that intersect imaging and biotechnology. His role at this prominent company emphasizes his influence in the field and his dedication to pioneering advances that can potentially revolutionize medical diagnostics.
Collaborations
Throughout his career, Aimiya has collaborated with noteworthy colleagues, including Hideki Gouda and Hisatake Okada. These partnerships foster knowledge exchange and innovation, allowing for the successful realization of complex projects that contribute to cutting-edge advancements in nanotecnology and medical research.
Conclusion
Takuji Aimiya's inventive spirit and expertise in nanoparticle technology position him as a significant figure in the realm of medical diagnostics and biological research. His ongoing contributions through patents and collaborations underline his commitment to improving healthcare outcomes and advancing scientific understanding.